Clomiphene: Scientific Profile
Publicado el · Actualizado el
Selective Estrogen Receptor Modulator (SERM) for research. It acts by blocking the negative feedback of estrogens on the hypothalamic-pituitary-gonadal axis.
Clomiphene is a synthetic organic compound classified as a selective estrogen receptor modulator (SERM). In research contexts, this agent demonstrates both agonist and antagonist properties at the estrogen receptors depending on the target tissue. Its main application in study models focuses on its ability to bind to the estrogen receptors in the hypothalamus, preventing endogenous estrogen from exerting its normal inhibitory effect.
This blockade of negative feedback results in an increase in the secretion of gonadotropin-releasing hormone (GnRH). Consequently, the anterior pituitary responds with an increased pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In male study subjects, the increase in LH stimulates Leydig cells, which translates into an elevation of intratesticular testosterone biosynthesis.
Research with Clomiphene is fundamental in protocols for restoring the hormonal axis after suppression induced by exogenous agents. Its pharmacokinetic profile indicates a prolonged half-life, which allows sustained modulation of gonadotropins. Current studies explore its efficacy in the preservation of spermatogenesis and the reversal of hypogonadotropic dysfunction in controlled laboratory settings.
Mechanism of action
The central mechanism consists of competitive antagonism of estrogen receptors at the hypothalamic level. By occupying these receptors, the compound prevents circulating estrogen from sending suppression signals. This induces a state of 'perceived hypoestrogenism' by the central nervous system, triggering a compensatory response that raises the production of pituitary gonadotropins (LH and FSH), optimizing the endogenous production of sex steroids.
Mechanism summary
It antagonizes estrogen receptors in the hypothalamus to induce GnRH release and raise the production of LH and FSH.
Estudios Clínicos (10)
- Clomid for unexplained infertility? Simple lie or complicated truth? (Mersol-Barg MS et al. · Fertility and sterility · 1994) PMID 7926109.
- [Clomid] (Csech J et al. · Soins. Gynecologie, obstetrique, puericulture, pediatrie · 1984) PMID 6564760.
- Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications (Wu, et al. · Pharmaceuticals (Basel) · 2024)
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials (Hohl, et al. · Archives of Endocrinology and Metabolism · 2025)
- Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism (Shabsigh, et al. · Journal of Sexual Medicine · 2005) PMID 16422830.
- Clomiphene citrate for male infertility: A systematic review and meta-analysis. (Huijben M, et al. · Andrology · 2023) PMID 36680549.
- Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. (Huijben M, et al. · Andrology · 2022) PMID 34933414.
- Letrozole Compared With Clomiphene Citrate for Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis. (Liu Z, et al. · Obstet Gynecol · 2023) PMID 36735392.
- Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. (Legro RS, et al. · N Engl J Med · 2014) PMID 25006718.
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. (Hohl A, et al. · Arch Endocrinol Metab · 2025) PMID 41066380.
Warnings
Clomiphene is a compound exclusively for research use (RUO); the following warnings and handling considerations apply to its use in the laboratory:
- Risk of irreversible changes in vision after prolonged exposure
- Necessary monitoring of serum estradiol levels
- For use only in controlled laboratory settings
- Presence of pre-existing hepatic dysfunction
- Hormone-dependent tumors
- Subject's hypersensitivity to the compound
- History of thromboembolic disorders
Technical data
- CAS
- 911-45-5
- Molecular formula
- C26H28ClNO
- Molecular weight
- 405.96 Da
- Compound type
- sarm
- Storage
- 15-30°C in a dry place protected from light
- Shelf life (lyophilized)
- 36 months
- Shelf life (reconstituted)
- Not applicable (solid formulation)
- Light-sensitive
- Sí
Frequently asked questions about Clomiphene
What is Clomiphene?
Selective Estrogen Receptor Modulator (SERM) for research. It acts by blocking the negative feedback of estrogens on the hypothalamic-pituitary-gonadal axis.
What is the mechanism of action of Clomiphene?
It antagonizes estrogen receptors in the hypothalamus to induce GnRH release and raise the production of LH and FSH.
What is Clomiphene researched for?
In preclinical research, Clomiphene is studied mainly in: Induction of the secretion of the gonadotropins LH and FSH; Research on the stimulation of endogenous testosterone; Modeling of the restoration of the hypothalamic-pituitary-gonadal axis. Material exclusively for scientific research.
What are the chemical properties of Clomiphene?
Molecular formula C26H28ClNO; molecular weight 405.96 Da; CAS number 911-45-5.
How is Clomiphene stored?
Storage conditions: 15-30°C in a dry place protected from light; lyophilized stability: 36 months; once reconstituted: Not applicable (solid formulation); protect from light.
What routes of administration are studied for Clomiphene?
In research models the following are described: Oral. Use is exclusively for scientific research.